Psyence Biomedical Ltd. Common Shares (PBM)

Psyence Biomedical Ltd. Common Shares (PBM) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $19.1M; returns 1 day +1.1%, 1 week -1.3%, 1 year -80.0%.

Psyence Biomedical Ltd. is a clinical-stage biopharmaceutical company focused on developing therapeutics from nature-derived psychedelic compounds, primarily psilocybin and ibogaine. The company is not currently generating revenue, as its business model is centered on advancing its product candidates through clinical trials to gain regulatory approval for commercialization.

Groups PBM belongs to

• Biotechnology
• Recent Reverse Splits
• Pharmaceuticals
• Canada Companies
• Biopharmaceutical
• Clinical Stage Biotech
• Clinical Stage Biopharma
• Healthcare
• Mental Health Solutions
• Neuroscience
• CNS Disorders
• Neurological Disorders

PBM financial model: income statement, cash flow and balance sheet